Silvestrol Exhibits Significant in Vivo and in Vitro Antileukemic Activities and Inhibits FLT3 and miR-155 Expressions in Acute Myeloid Leukemia

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/1756-8722-6-21
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

NF-κB/STAT5/miR-155 Network Targets PU.1 in FLT3-ITD-driven Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2014English

SHIP1 Is Targeted by miR-155 in Acute Myeloid Leukemia

Oncology Reports
MedicineCancer ResearchOncology
2014English

Downregulation of Mir-31, Mir-155, and Mir-564 in Chronic Myeloid Leukemia Cells

PLoS ONE
Multidisciplinary
2012English

FLT3-TKD Mutation in Childhood Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2003English

A Novel, Dual Pan-Pim/Flt3 Inhibitor SEL24 Exhibits Broad Therapeutic Potential in Acute Myeloid Leukemia

Oncotarget
Oncology
2018English

FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2011English

Overexpression of MYCT1 Inhibits Proliferation and Induces Apoptosis in Human Acute Myeloid Leukemia HL-60 and KG-1a Cells in Vitro and in Vivo

Frontiers in Pharmacology
Pharmacology
2018English

3, 3′-Diindolylmethane Exhibits Antileukemic Activity in Vitro and in Vivo Through a Akt-Dependent Process

PLoS ONE
Multidisciplinary
2012English

CD123 Targeting Oncolytic Adenoviruses Suppress Acute Myeloid Leukemia Cell Proliferation in Vitro and in Vivo

Blood Cancer Journal
OncologyHematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy